US Patent 9211263 Compositions and methods of treating metabolic disorders
Patent 9211263 was granted and assigned to Elcelyx Therapeutics Inc. on December, 2015 by the United States Patent and Trademark Office.
Is a
Date Filed
January 5, 2013
Date of Patent
December 15, 2015
Patent Application Number
13734966
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9211263 Compositions and methods of treating metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.